Related Experiment Video
Updated: Jan 18, 2026
05:19
A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
Published on: November 7, 2025
677
Geriatric oncology: problems with under-treatment within this population
Divya Swaminathan1, Vikram Swaminathan1
11 Norwich Medical School, University of East Anglia, Norwich NR4 7TJ, UK ; 2 Health Education North West, Liverpool L3 4BL, UK.
Cancer Biology & Medicine
|January 19, 2016
Summary
Older adults face ageist stereotypes impacting cancer care. This review highlights concerns and under-treatment in elderly cancer patients, advocating for better management strategies.
Area of Science:
- Gerontology
- Oncology
- Public Health
Background:
- The global population is aging rapidly, with individuals over 65 accounting for two-thirds of all cancer cases.
- Societal ageist stereotypes associate old age with frailty and loss of independence, influencing perceptions of elderly individuals.
- These stereotypes extend to cancer care, leading to misconceptions about the recovery potential of elderly cancer patients compared to younger counterparts.
Purpose of the Study:
- To review current concerns in the management of oncological disease in the elderly population.
- To examine treatments utilized for elderly cancer patients.
- To discuss the impact of under-treatment on this demographic.
Main Methods:
- Systematic literature review of current concerns and management strategies for elderly cancer patients.
- Analysis of treatment modalities employed in geriatric oncology.
- Discussion of the consequences of suboptimal treatment in older adults with cancer.
Main Results:
- Elderly cancer patients are often subject to ageist stereotypes, potentially affecting treatment decisions.
- Under-treatment of cancer in the elderly is a significant concern, potentially linked to perceived lower recovery rates.
- Existing management strategies may not adequately address the unique needs of older adults with cancer.
Conclusions:
- Addressing ageist stereotypes is crucial for equitable cancer care in older adults.
- Optimizing treatment strategies for elderly cancer patients is essential to improve outcomes.
- Further research and policy changes are needed to combat under-treatment and enhance geriatric oncology care.
More Related Videos
Related Concept Videos
01:15Drug Dosing: Geriatric Patients
228
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
228
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
238
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
238
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
234
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
234
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
198
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
198
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
190
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
190
02:56Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K